4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-308058
Chief Financial Officer sold 40,000 shares at an average $87.71 ($3,508,277)
- Chief Financial Officer acquired 40,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Mokari Atabak · Chief Financial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +15,833 | $19.26 | $304,944 | 31,963 | D |
| 2026-07-15 | Exercise or conversion : show line 2 in the form 10b5-1 | +24,167 | $23.06 | $557,291 | 56,130 | D |
| 2026-07-15 | Sale : show line 3 in the form 10b5-1 | −7,919 | $86.78 | $687,179 | 48,211 | D |
| 2026-07-15 | Sale : show line 4 in the form 10b5-1 | −28,460 | $87.89 | $2,501,244 | 19,751 | D |
| 2026-07-15 | Sale : show line 5 in the form 10b5-1 | −3,520 | $88.30 | $310,822 | 16,231 | D |
| 2026-07-15 | Sale : show line 6 in the form 10b5-1 | −101 | $89.43 | $9,032 | 16,130 | D |
| Open-market sales · 40,000 sh · avg $87.71 · $3,508,277 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-15 | Exercise or conversion : show line 7 in the form 10b5-1 Stock option (right to buy) | −15,833 | 4,167 | D |
| 2026-07-15 | Exercise or conversion : show line 8 in the form 10b5-1 Stock option (right to buy) | −24,167 | 175,833 | D |
Loading xslF345X06/ownership.xml…